Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,192 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

NCT05959083

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Peking University Third Hospital /ID# 257722 Beijing, Beijing Municipality, China
  • The First Affiliated Hospital Of Fujian Medical University /ID# 257725 Fuzhou, Fujian, China
  • Dermatology Hospital of Southern Medical University /ID# 261862 Guangzhou, Guangdong, China
  • The Eighth Affiliated Hospital, Sun Yat-sen universtiy /ID# 257737 Shenzhen, Guangdong, China
View all 18 locations
View Trial Details
Completed

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

NCT05436535

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • University of California, San Diego: Dermatology Clinical Trials Unit La Jolla, California, United States
  • Children's Hospital Los Angeles: Division of Clinical Immunology & Allergy Los Angeles, California, United States
  • National Jewish Health: Division of Pediatric Allergy and Clinical Immunology Denver, Colorado, United States
  • Boston Children's Hospital: Department of Immunology Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)

NCT03607422

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Total Skin and Beauty Derm Ctr /ID# 205129 Birmingham, Alabama, United States
  • Medical Dermatology Specialist /ID# 205516 Phoenix, Arizona, United States
  • Arizona Research Center, Inc. /ID# 205795 Phoenix, Arizona, United States
  • The Dermatology Clinic of Arkansas /ID# 218749 Bryant, Arkansas, United States
View all 196 locations
View Trial Details
Completed

A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

NCT04365387

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +13 more
Locations
  • Galderma Investigational Site (Site#9922) Phoenix, Arizona, United States
  • Galderma Investigational Site (Site#8873) Scottsdale, Arizona, United States
  • Galderma Investigational Site (Site#8447) Fort Smith, Arkansas, United States
  • Galderma Investigational Site (Site#8831) Anaheim, California, United States
View all 64 locations
View Trial Details
Completed

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

NCT05590585

Conditions
Atopic Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +14 more
Locations
  • Total Skin & Beauty Dermatology Center Birmingham, Alabama, United States
  • The University Of Alabama At Birmingham Birmingham, Alabama, United States
  • C2 Research Center, LLC Montgomery, Alabama, United States
  • Center for Dermatology Clinical Research, inc. Fremont, California, United States
View all 30 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

NCT06238817

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +14 more
Locations
  • Lynn Institute of the Ozarks Little Rock, Arkansas, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Center For Dermatology Cosmetic and Laser Surgery Fremont, California, United States
  • Medderm Associates, Inc San Diego, California, United States
View all 94 locations
View Trial Details
Completed

Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis

NCT05916365

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigator Site 7 Darmstadt, Hesse, Germany
  • Investigator Site 8 Frankfurt am Main, Hesse, Germany
  • Investigator Site 10 Bad Bentheim, Lower Saxony, Germany
  • Investigator Site 9 Osnabrück, Lower Saxony, Germany
View all 32 locations
View Trial Details
Completed

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)

NCT05388760

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • LEO Pharma Investigational Site Brno, Czechia
  • LEO Pharma Investigational Site Prague, Czechia
  • LEO Pharma Investigational Site Reims, Ardennes, France
  • LEO Pharma Investigational Site Rotterdam, Netherlands
View Trial Details

Related conditions